In Vitro and In Vivo Assays to Analyze the Contribution of Rho Kinase in Angiogenesis

Methods in Enzymology

Volumn 439, Issue , 2008, Pages 395-412

  Sawada, Kenjiro ^a   Morishige, Ken ichirou ^a   Mabuchi, Seiji ^a   Ogata, Seiji ^a   Kawase, Chiaki ^a   Sakata, Masahiro ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALENDRONIC ACID; CD31 ANTIGEN; FASUDIL; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; RHO KINASE INHIBITOR; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; DRUG DERIVATIVE; VASCULOTROPIN A;

ANGIOGENESIS; CANCER THERAPY; CELL FUNCTION; CELL MIGRATION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CYTOSKELETON; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ASSAY; ENZYME MECHANISM; FOCAL ADHESION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STRESS FIBER; TARGET CELL; UMBILICAL VEIN; ANIMAL; ARTICLE; CELL MIGRATION ASSAY; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; METHODOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ALENDRONATE; ANIMALS; CELL CULTURE TECHNIQUES; CELL MIGRATION ASSAYS; ENDOTHELIUM, VASCULAR; FOCAL ADHESIONS; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RHO-ASSOCIATED KINASES; TRANSFECTION; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 45549096920     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)00428-4     Document Type: Review

References (37)

1. Amano M., Chihara K., Nakamura N., Fukata Y., Yano T., Shibata M., Ikebe M., and Kaibuchi K. Myosin II activation promotes neurite retraction during the action of Rho and Rho-kinase. Genes Cells 3 (1998) 177-188
2. Asano T., Ikegaki I., Satoh S., Suzuki Y., Shibuya M., Takayasu M., and Hidaka H. Mechanism of action of a novel antivasospasm drug, HA1077. J. Pharmacol. Exp. Ther. 241 (1987) 1033-1040
3. Baudin B., Bruneel A., Bosselut N., and Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc. 2 (2007) 481-485
4. Fisher J.E., Rogers M.J., Halasy J.M., Luckman S.P., Hughes D.E., Masarachia P.J., Wesolowski G., Russell R.G., Rodan G.A., and Reszka A.A. Alendronate mechanism of action: Geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc. Natl. Acad. Sci. USA 96 (1999) 133-138
5. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1 (1995) 27-31
6. Fukata Y., Amano M., and Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends. Pharmacol. Sci. 22 (2001) 32-39
7. Guedez L., Rivera A.M., Salloum R., Miller M.L., Diegmueller J.J., Bungay P.M., and Stetler-Stevenson W.G. Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay. Am. J. Pathol. 162 (2003) 1431-1439
8. Halasy-Nagy J.M., Rodan G.A., and Reszka A.A. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone 29 (2001) 553-559
9. Hashimoto K., Morishige K., Sawada K., Tahara M., Shimizu S., Ogata S., Sakata M., Tasaka K., and Kimura T. Alendronate suppresses tumor angiogenesis by inhibiting Rho activation of endothelial cells. Biochem. Biophys. Res. Commun. 354 (2007) 478-484
10. Haudenschild C.C., and Schwartz S.M. Endothelial regeneration. II. Restitution of endothelial continuity. Lab Invest. 41 (1979) 407-418
11. Hill C.S., Wynne J., and Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81 (1995) 1159-1170
12. Hoeben A., Landuyt B., Highley M.S., Wildiers H., Van Oosterom A.T., and De Bruijn E.A. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 56 (2004) 549-580
13. Horwitz A.R., and Parsons J.T. Cell migration: Movin' on. Science 286 (1999) 1102-1103
14. Hotchin N.A., Cover T.L., and Akhtar N. Cell vacuolation induced by the VacA cytotoxin of Helicobacter pylori is regulated by the Rac1 GTPase. J. Biol. Chem. 275 (2000) 14009-14012
15. Huot J., Houle F., Rousseau S., Deschesnes R.G., Shah G.M., and Landry J. SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J. Cell Biol. 143 (1998) 1361-1373
16. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J. Clin. Invest. 52 (1973) 2745-2756
17. Katoh K., Kano Y., Masuda M., Onishi H., and Fujiwara K. Isolation and contraction of the stress fiber. Mol. Biol. Cell. 9 (1998) 1919-1938
18. Kimura K., Ito M., Amano M., Chihara K., Fukata Y., Nakafuku M., Yamamori B., Feng J., Nakano T., Okawa K., Iwamatsu A., and Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273 (1996) 245-248
19. Kiosses W.B., Daniels R.H., Otey C., Bokoch G.M., and Schwartz M.A. A role for p21-activated kinase in endothelial cell migration. J. Cell Biol. 147 (1999) 831-844
20. Le Boeuf F., Houle F., and Huot J. Regulation of vascular endothelial growth factor receptor 2-mediated phosphorylation of focal adhesion kinase by heat shock protein 90 and Src kinase activities. J. Biol. Chem. 279 (2004) 39175-39185
21. Liang C.C., Park A.Y., and Guan J.L. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2 (2007) 329-333
22. Narumiya S. The small GTPase Rho: Cellular functions and signal transduction. J Biochem. (Tokyo) 120 (1996) 215-228
23. Ridley A.J. Stress fibres take shape. Nat Cell Biol. 1 (1999) E64-E66
24. Ridley A.J., and Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70 (1992) 389-399
25. Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., and Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70 (1992) 401-410
26. Risau W., and Flamme I. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11 (1995) 73-91
27. Rousseau S., Houle F., Kotanides H., Witte L., Waltenberger J., Landry J., and Huot J. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J. Biol. Chem. 275 (2000) 10661-10672
28. Sawada K., Morishige K., Tahara M., Ikebuchi Y., Kawagishi R., Tasaka K., and Murata Y. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells. Gynecol. Oncol. 87 (2002) 252-259
29. Sawada K., Morishige K., Tahara M., Kawagishi R., Ikebuchi Y., Tasaka K., and Murata Y. Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho. Cancer Res. 62 (2002) 6015-6020
30. Shimokawa H., Seto M., Katsumata N., Amano M., Kozai T., Yamawaki T., Kuwata K., Kandabashi T., Egashira K., Ikegaki I., Asano T., Kaibuchi K., et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res. 43 (1999) 1029-1039
31. Shimokawa H., and Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb. Vasc. Biol. 25 (2005) 1767-1775
32. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., Tamakawa H., Yamagami K., Inui J., Maekawa M., and Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 (1997) 990-994
33. van Nieuw Amerongen G.P., Koolwijk P., Versteilen A., and van Hinsbergh V.W. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb. Vasc. Biol. 23 (2003) 211-217
34. Waterman-Storer C.M., Worthylake R.A., Liu B.P., Burridge K., and Salmon E.D. Microtubule growth activates Rac1 to promote lamellipodial protrusion in fibroblasts. Nat. Cell Biol. 1 (1999) 45-50
35. White G.E., Gimbrone Jr. M.A., and Fujiwara K. Factors influencing the expression of stress fibers in vascular endothelial cells in situ. J. Cell Biol. 97 (1983) 416-424
36. Yin L., Morishige K., Takahashi T., Hashimoto K., Ogata S., Tsutsumi S., Takata K., Ohta T., Kawagoe J., Takahashi K., and Kurachi H. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Mol. Cancer Ther. 6 (2007) 1517-1525
37. Ying H., Biroc S.L., Li W.W., Alicke B., Xuan J.A., Pagila R., Ohashi Y., Okada T., Kamata Y., and Dinter H. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Mol. Cancer Ther. 5 (2006) 2158-2164